FDA and Boehringer Ingelheim on October 16 announced the approval of idarucizumab injection to reverse the anticoagulant effects of dabigatran.
The seemingly common practice at pharmacies and outsourcing facilities of storing sterile compounded preparations or repackaging sterile pharmaceuticals in drug-administration
The old rallying call of independent pharmacies—"Get into politics or get out of pharmacy"—still holds true today and applies to all segments of the profession,
Asfotase alfa, a tissue nonspecific alkaline phosphatase produced by recombinant DNA technology, was approved by FDA on October 23 and, according to manufacturer
President Barack Obama this afternoon visited Charleston, West Virginia, to listen to local concerns about the epidemic of opioid abuse and death and to announce
FDA on Tuesday announced the approval of human plasma–derived coagulation factor X as a replacement therapy for patients 12 years of age or older with hereditary